
JPXHealthcareMedical - Distribution
Latest quote
¥5,162
−¥27.00 · -0.52%
Suzuken Co., Ltd., along with its affiliated companies, operates primarily as a wholesale distributor of pharmaceuticals, serving both domestic and international markets. The company's diverse activities are organized into four distinct divisions. Its Pharmaceutical Distribution Business focuses on sourcing a wide array of products, including ethical drugs, diagnostic reagents, medical devices, and other health-related items directly from manufacturers, and then supplying these to healthcare institutions and pharmacies. The Pharmaceutical Manufacturing Business is dedicated to the research, development, production, and commercialization of prescription pharmaceuticals and diagnostic tools, with a particular emphasis on diabetes and kidney-related conditions. Through its Pharmacy Business segment, Suzuken offers services via family pharmacists, works to enhance the efficiency of local pharmacy operations, and provides educational support. The Healthcare-Related Services Business encompasses a variety of support functions, such as contract distribution for manufacturers, the distribution of orphan drugs, and nursing care services. This segment is also involved in the development, manufacturing, and sale of medical equipment, including electrocardiographs, blood pressure monitors, stethoscopes, general medical supplies, and health promotion devices. Furthermore, Suzuken Co., Ltd. publishes medical journals for healthcare professionals and collaborates with Bushu Pharmaceuticals Ltd. to provide specialized contract drug services. The company was established in 1932 and is headquartered in Nagoya, Japan.
Latest quote
¥5,162
−¥27.00 · -0.52%
Regular session · JST · Market data may be delayed.
Suzuken Co., Ltd., along with its affiliated companies, operates primarily as a wholesale distributor of pharmaceuticals, serving both domestic and international markets. The company's diverse activities are organized into four distinct divisions. Its Pharmaceutical Distribution Business focuses on sourcing a wide array of products, including ethical drugs, diagnostic reagents, medical devices, and other health-related items directly from manufacturers, and then supplying these to healthcare institutions and pharmacies. The Pharmaceutical Manufacturing Business is dedicated to the research, development, production, and commercialization of prescription pharmaceuticals and diagnostic tools, with a particular emphasis on diabetes and kidney-related conditions. Through its Pharmacy Business segment, Suzuken offers services via family pharmacists, works to enhance the efficiency of local pharmacy operations, and provides educational support. The Healthcare-Related Services Business encompasses a variety of support functions, such as contract distribution for manufacturers, the distribution of orphan drugs, and nursing care services. This segment is also involved in the development, manufacturing, and sale of medical equipment, including electrocardiographs, blood pressure monitors, stethoscopes, general medical supplies, and health promotion devices. Furthermore, Suzuken Co., Ltd. publishes medical journals for healthcare professionals and collaborates with Bushu Pharmaceuticals Ltd. to provide specialized contract drug services. The company was established in 1932 and is headquartered in Nagoya, Japan.
Day range
Current ¥5,162
52-week range
Current ¥5,162
Regular session · JST · Market data may be delayed.
Suzuken Co., Ltd., along with its affiliated companies, operates primarily as a wholesale distributor of pharmaceuticals, serving both domestic and international markets. The company's diverse activities are organized into four distinct divisions. Its Pharmaceutical Distribution Business focuses on sourcing a wide array of products, including ethical drugs, diagnostic reagents, medical devices, and other health-related items directly from manufacturers, and then supplying these to healthcare institutions and pharmacies. The Pharmaceutical Manufacturing Business is dedicated to the research, development, production, and commercialization of prescription pharmaceuticals and diagnostic tools, with a particular emphasis on diabetes and kidney-related conditions. Through its Pharmacy Business segment, Suzuken offers services via family pharmacists, works to enhance the efficiency of local pharmacy operations, and provides educational support. The Healthcare-Related Services Business encompasses a variety of support functions, such as contract distribution for manufacturers, the distribution of orphan drugs, and nursing care services. This segment is also involved in the development, manufacturing, and sale of medical equipment, including electrocardiographs, blood pressure monitors, stethoscopes, general medical supplies, and health promotion devices. Furthermore, Suzuken Co., Ltd. publishes medical journals for healthcare professionals and collaborates with Bushu Pharmaceuticals Ltd. to provide specialized contract drug services. The company was established in 1932 and is headquartered in Nagoya, Japan.
Day range
Current ¥5,162
52-week range
Current ¥5,162
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 2.49T JPY | 2.4T JPY | 2.39T JPY | 2.31T JPY | 2.24T JPY |
| Cost of goods sold | 2.29T JPY | 2.21T JPY | 2.2T JPY | 2.14T JPY | 2.07T JPY |
| Gross profit | 192.53B JPY | 192.23B JPY | 185.25B JPY | 179.7B JPY | 167.33B JPY |
| Research and development | — | 3.52B JPY | 3.28B JPY | 2.95B JPY | 4.59B JPY |
| Selling, general, and administrative | 156.15B JPY | 151.58B JPY | 147.09B JPY | 144.14B JPY | 142.62B JPY |
| Operating expenses | 156.15B JPY | 155.11B JPY | 150.37B JPY | 147.09B JPY | 147.22B JPY |
| Interest income | 158M JPY | 182M JPY | 166M JPY | 171M JPY | 196M JPY |
| Interest expense | 42M JPY | 41M JPY | 43M JPY | 42M JPY | 51M JPY |
| Depreciation and amortization | 12.34B JPY | 12.06B JPY | 8.74B JPY | 8.84B JPY | 10.02B JPY |
| Operating income | 36.38B JPY | 37.13B JPY | 34.88B JPY | 32.61B JPY | 20.12B JPY |
| Net income | 38.14B JPY | 34.5B JPY | 29.02B JPY | 20.35B JPY | 14.39B JPY |
Company facts updated Sep 6, 2026.
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
¥100
2025 complete year+38.9% since 2021
2026 partial: ¥50.00
¥72.00
2,021
¥72.00
2,022
¥76.00
2,023
¥90.00
2,024
¥100
2,025
¥50.00
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Sep 29, 2026 | ¥60.00Semi-Annual | Sep 30, 2026 | Sep 29, 2026 |
DividendUpcoming | Mar 30, 2027 | ¥30.00Semi-Annual | Mar 31, 2027 | Mar 30, 2027 |
Dividend | Mar 30, 2026 | ¥50.00Semi-Annual | Mar 31, 2026 | Jun 3, 2026 |
Dividend | Sep 29, 2025 | ¥50.00Semi-Annual | Sep 30, 2025 | Dec 10, 2025 |
Dividend | Mar 28, 2025 | ¥50.00Semi-Annual | Mar 31, 2025 | Jun 4, 2025 |
Dividend | Sep 27, 2024 | ¥50.00Semi-Annual | Sep 30, 2024 | Dec 10, 2024 |
Ex-dividend Sep 29, 2026
¥60.00
Semi-Annual
Record Sep 30, 2026 · Payment Sep 29, 2026
Ex-dividend Mar 30, 2027
¥30.00
Semi-Annual
Record Mar 31, 2027 · Payment Mar 30, 2027
Ex-dividend Mar 30, 2026
¥50.00
Semi-Annual
Record Mar 31, 2026 · Payment Jun 3, 2026
Ex-dividend Sep 29, 2025
¥50.00
Semi-Annual
Record Sep 30, 2025 · Payment Dec 10, 2025
Ex-dividend Mar 28, 2025
¥50.00
Semi-Annual
Record Mar 31, 2025 · Payment Jun 4, 2025
Ex-dividend Sep 27, 2024
¥50.00
Semi-Annual
Record Sep 30, 2024 · Payment Dec 10, 2024
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core TOPIX ETF1475.T940.53M0.03%2.9T JPY0.05%¥421.6+0.12%
Vanguard Total International Stock ETFVXUS26.13M0.00%646.2B USD0.05%$88.41+0.50%
Avantis International Small Cap Value ETFAVDV21.83M0.11%20.38B USD0.36%$113.75+0.07%
Vanguard FTSE Developed Markets ETFVEA17.18M0.01%315B USD0.03%$73.76+0.44%
iShares Core MSCI EAFE ETFIEFA13.44M0.01%193.86B USD0.07%$101.08+0.13%
Schwab Fundamental International Large Company Index ETFFNDF6.62M0.03%26B USD0.25%$56.31+0.23%
Dimensional - International Small Cap Value ETFDISV6.49M0.12%5.24B USD0.42%$44.98+0.04%
iShares MSCI EAFE Small-Cap ETFSCZ6.41M0.05%13.11B USD0.40%$87.57+0.10%
iShares Core TOPIX ETF1475.T
Vanguard Total International Stock ETFVXUS
Avantis International Small Cap Value ETFAVDV
Vanguard FTSE Developed Markets ETFVEA
iShares Core MSCI EAFE ETFIEFA
Schwab Fundamental International Large Company Index ETFFNDF
Dimensional - International Small Cap Value ETFDISV
iShares MSCI EAFE Small-Cap ETFSCZAI-generated and delayed market data for informational and educational purposes only. Not investment advice.